22157.jpg
Global Pharma, Biotech & Diagnostics Collaborative R&D Deals Directory 2015-2021
May 05, 2021 04:23 ET | Research and Markets
Dublin, May 05, 2021 (GLOBE NEWSWIRE) -- The "Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2015-2021" report has been added to...
22157.jpg
Global Pharma, Biotech & Diagnostics Licensing Partnering Terms & Agreements Directory/Report 2014-2020
April 01, 2021 05:08 ET | Research and Markets
Dublin, April 01, 2021 (GLOBE NEWSWIRE) -- The "Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2020" report has been added to ResearchAndMarkets.com's...
22157.jpg
Global Orphan Diseases Partnering Deal Trends, Players and Financials Directory 2020: Comprehensive Access to Over 230 Orphan Diseases Deal Records
March 26, 2021 05:53 ET | Research and Markets
Dublin, March 26, 2021 (GLOBE NEWSWIRE) -- The "Global Orphan Diseases Partnering 2010-2020: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering. The...
22157.jpg
Global Big Pharma Partnering Deals, Terms and Agreements Directory 2021: Comprehensive Listing of the Top 50 Companies Including Pfizer, Sanofi, Abbott, GlaxoSmithKline, Johnson & Johnson
March 12, 2021 06:28 ET | Research and Markets
Dublin, March 12, 2021 (GLOBE NEWSWIRE) -- The "Global Big Pharma Partnering Terms and Agreements 2014-2021" report has been added to ResearchAndMarkets.com's offering. The Global Big Pharma...
22157.jpg
Global Pharma, Biotech & Diagnostics Collaborative R&D Deals Directory 2020: Comprehensive Listing of Over 5,500 Collaborative R&D Deals Since 2014
February 05, 2021 06:38 ET | Research and Markets
Dublin, Feb. 05, 2021 (GLOBE NEWSWIRE) -- The "Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2014-2020" report has been added to...
OptimizeRx Uplists to the Nasdaq Capital Market
June 19, 2018 11:45 ET | OptimizeRx Corporation
ROCHESTER, Mich., June 19, 2018 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ:OPRX), a leading global provider of digital health messaging for the pharmaceutical industry, has uplisted to the Nasdaq...
OptimizeRx.png
OptimizeRx to Launch Real-time Financial Messaging With Modernizing Medicine, Providing Prescription Cost Savings at Point-of-Care
December 06, 2017 08:31 ET | OptimizeRx Corporation; Modernizing Medicine
ROCHESTER, Mich. and BOCA RATON, Fla., Dec. 06, 2017 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (OTCQB:OPRX), the nation’s leading provider of digital health messaging via electronic health record (EHR)...
InspireLogo_Together_July2016.jpg
In new survey of patients, Inspire examines clinical trials, genetic testing
December 05, 2017 12:00 ET | Inspire
ARLINGTON, Va., Dec. 05, 2017 (GLOBE NEWSWIRE) -- In a new survey by Inspire, three of 10 respondents say they have talked to their doctors about enrolling in clinical trials, and about 14% actually...
OptimizeRx.png
OptimizeRx Sets Third Quarter 2017 Conference Call for Thursday, November 2, 2017 at 4:30 p.m. ET
October 19, 2017 08:31 ET | OptimizeRx Corporation
ROCHESTER, Mich., Oct. 19, 2017 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (OTCQB:OPRX), the nation’s leading provider of digital health messaging via electronic health records (EHRs), will hold a...
InspireLogo_Together_July2016.jpg
Inspire expands patient engagement product portfolio
September 27, 2017 07:00 ET | Inspire
ARLINGTON, Va., Sept. 27, 2017 (GLOBE NEWSWIRE) -- Healthcare social network Inspire is now offering sponsored content as part of its Inspire EngageTM product portfolio for its life science clients....